4.4 Article

Predictors for Celiac Disease in Adult Cases of Duodenal Intraepithelial Lymphocytosis

Journal

JOURNAL OF CLINICAL GASTROENTEROLOGY
Volume 49, Issue 6, Pages 477-482

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCG.0000000000000184

Keywords

duodenal intraepithelial lymphocytosis; celiac disease; nonceliac disease

Funding

  1. Cancer Research UK [16491] Funding Source: researchfish

Ask authors/readers for more resources

Background:Duodenal intraepithelial lymphocytosis (D-IEL) is an early marker for celiac disease (CD). However, the majority of cases are due to non-CD-related conditions.Goals:To identify the predictors of CD when presented with D-IEL.Methods:A total of 215 adult patients with D-IEL had undergone prospective and systematic evaluation for CD and other recognized associations.The gold-standard diagnosis of CD was based upon the presence of HLA-DQ2 and/or DQ8, persistence or progression of D-IEL following a gluten challenge, followed by symptomatic improvement on a gluten-free diet.Binary logistic regression models, adjusting for age and sex, were subsequently performed to compare presenting variables between CD and non-CD cases, and to determine their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).Results:CD was diagnosed in 48 cases (22%) and non-CD in 167 cases (78%). There was no statistical difference in baseline demographics, clinical symptoms (ie, diarrhea, weight loss, abdominal pain), anemia, or hematinics between the CD and non-CD group.Patients with CD, in comparison with non-CD, were significantly more likely to have a positive family history of CD (21% vs. 3.6%, OR 6.73; PPV 62.5%, NPV 81%, specificity 96.4%), positive HLA-DQ status (100% vs. 49.1%; PPV 36.4%, NPV 100%, specificity 50.9%), and presence of endomysial antibody (EMA) (48% vs. 0%; PPV 100%, NPV 87%, specificity 100%); all P0.001.A normal tissue transglutaminase antibody (TTG) level was seen in 29.2% CD and 83.2% non-CD cases (OR 0.084, P<0.001; PPV 9.2%). There was no difference in the prevalence of TTG levels 1 to 2xupper limit of normal (ULN) between the groups (29.2% CD vs. 14.4% non-CD; PPV 33% to 38%). However, TTG levels between 3 and 20xULN were significantly more prevalent in the CD group (33.3% vs. 2.4%, PPV 66.6% to 89%), whereas a TTG>20xULN was exclusive to CD (8.3%, P<0.001, PPV 100%).Conclusions:In the setting of D-IEL, only the presence of a positive EMA or TTG>20xULN at the outset can be used to make an immediate diagnosis of CD. Gastrointestinal symptoms, family history, anemia, or other celiac serology results do not reliably distinguish CD from non-CD without further investigations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Gastroenterology & Hepatology

Is CBT the dominant non-drug IBS treatment? The rise of dietary therapies

Anupam Rej, Rachel Louise Buckle, Christian Charles Shaw, Nick Trott, Imran Aziz, David S. Sanders

Article Gastroenterology & Hepatology

Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders

Zohaib Asghar, Mo Thoufeeq, Matthew Kurien, Alex J. Ball, Anupam Rej, Foong Way David Tai, Shima Afify, Imran Aziz

Summary: There is limited data on the diagnostic yield of colonoscopy in patients with symptoms compatible with functional bowel disorders (FBDs). This study aimed to determine the diagnostic outcomes of colonoscopy in FBD patients using Rome IV criteria and categorizing them based on the presence or absence of alarm features. The presence of organic disease was found to be significantly higher in patients with diarrheal disorders compared to constipation disorders, mainly due to microscopic colitis. Colonoscopy had no diagnostic value in patients without alarm features.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Editorial Material Gastroenterology & Hepatology

Personalizing Dietary Therapies For Irritable Bowel Syndrome: What Is Gluten's Role?

Anupam Rej, Imran Aziz, David S. Sanders

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Letter Gastroenterology & Hepatology

What is the optimal FODMAP threshold in IBS?

A. Rej, D. S. Sanders, R. L. Buckle, N. Trott, I Aziz, C. C. Shaw

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease

Sophie Parker, Olafur Palsson, David S. Sanders, Magnus Simren, Ami D. Sperber, Hans Tornblom, Heidi Urwin, William Whitehead, Imran Aziz

Summary: Individuals with celiac disease can experience gastrointestinal symptoms despite adhering to a gluten-free diet. This study found that half of the individuals with celiac disease who adhered to a gluten-free diet had functional gastrointestinal disorders, which was twice the rate compared to a matched control group. Furthermore, these individuals were more likely to have anxiety, depression, somatization, and reduced quality of life. Addressing gut-brain interaction disorders may improve outcomes in this specific group of patients.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet

Anupam Rej, David S. Sanders, Christian C. Shaw, Rachel Buckle, Nick Trott, Anurag Agrawal, Imran Aziz

Summary: This randomized trial compared the efficacy of traditional dietary advice (TDA) with low FODMAP diet (LFD) and gluten-free diet (GFD) in patients with non-constipated irritable bowel syndrome (IBS). The results showed that while all three diets were effective, TDA was the most suitable for patients in terms of cost and convenience.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life

Ami D. Sperber, Tamar Freud, Imran Aziz, Olafur S. Palsson, Douglas A. Drossman, Dan L. Dumitrascu, Xuicai Fang, Shin Fukudo, Uday C. Ghoshal, John Kellow, Rutaba Khatun, Edith Okeke, Eamonn M. M. Quigley, Max Schmulson, Magnus Simren, Jan Tack, William E. Whitehead, Peter Whorwell, Shrikant Bangdiwala

Summary: Gastrointestinal disorders such as irritable bowel syndrome can have negative effects on patients' lives. This study found that 40.3% of surveyed individuals met the criteria for disorders of gut-brain interaction and that DGBI in multiple anatomic gastrointestinal regions is associated with increased psychological comorbidity, healthcare utilization, and IBS severity.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Reply

Anupam Rej, David S. Sanders, Imran Aziz

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

Further research needed to determine first-line therapy for IBS in primary care

Anupam Rej, David S. Sanders, Imran Aziz

Article Gastroenterology & Hepatology

British Society of Gastroenterology guidelines on the management of functional dyspepsia

Christopher J. Black, Peter A. Paine, Anurag Agrawal, Imran Aziz, Maria P. Eugenicos, Lesley A. Houghton, Pali Hungin, Ross Overshott, Dipesh H. Vasant, Sheryl Rudd, Richard C. Winning, Maura Corsetti, Alexander C. Ford

Summary: This research aims to review and summarize the current evidence on functional dyspepsia, provide a practical framework for evidence-based diagnosis and treatment of patients, and provide specific recommendations based on the GRADE system. The study also considers the development of novel treatment methods and highlights areas of unmet need and priorities for future research.
Article Gastroenterology & Hepatology

Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education

Julia Simons, Umair Shajee, Olafur Palsson, Magnus Simren, Ami D. Sperber, Hans Tornblom, William Whitehead, Imran Aziz

Summary: This study aimed to determine the prevalence and health impairment of disorders of gut-brain interaction (DGBI) in Great Britain and their emphasis in medical education. The results showed that DGBI are common in Great Britain and have a significant impact on health, but they are generally under-taught in the British medical education system. Increasing awareness and education on DGBI may improve patient outcomes.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2022)

Review Medicine, General & Internal

Diet and irritable bowel syndrome: an update from a UK consensus meeting

A. Rej, A. Avery, I Aziz, C. J. Black, R. K. Bowyer, R. L. Buckle, L. Seamark, C. C. Shaw, J. Thompson, N. Trott, M. Williams, D. S. Sanders

Summary: There is a renewed interest in using dietary therapies to manage irritable bowel syndrome (IBS), with traditional dietary advice (TDA), gluten-free diet (GFD) and low FODMAP diet (LFD) being the main focus. Evidence shows that TDA is effective based on case control studies and clinical experience, while randomized controlled trials (RCT) have proven the benefits of soluble fiber in IBS. Short-term studies show the efficacy of GFD, but long-term outcomes are lacking. LFD has good evidence for short-term and long-term benefits. There is currently no evidence to suggest one diet is superior to another, but TDA is more acceptable to patients. Dietitians should assess dietary triggers and tailor interventions according to patient choice. Alternative approaches like group clinics and online webinars can improve accessibility for patients. Further research is needed to compare dietary therapies with other management strategies for IBS.

BMC MEDICINE (2022)

Article Oncology

Fecal Immunochemical Testing in Patients With Low-Risk Symptoms of Colorectal Cancer: A Diagnostic Accuracy Study

Alex J. Ball, Imran Aziz, Sophie Parker, Ravishankar B. Sargur, Jonathan Aldis, Matthew Kurien

Summary: This study demonstrates that using FIT as a triage method for low-risk symptomatic primary care patients is safe and effective. FIT has high sensitivity and specificity for detecting CRC at a threshold of >= 10 mu g/g.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Article Gastroenterology & Hepatology

Diagnostic yield of upper gastrointestinal endoscopy in patients attending a UK centre with symptoms compatible with Rome IV functional dyspepsia

Hannah Lorraine-Francis, Ellen Newberry, Imran Aziz

Summary: Approximately 1 in 10 upper gastrointestinal endoscopies are performed in patients with symptoms compatible with FD and no alarm features, but these endoscopies do not provide any diagnostic yield. It is recommended to diagnose FD in these patients without the need for endoscopy.

FRONTLINE GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study

Hussain Jaafari, Lesley A. Houghton, Robert M. West, Anurag Agrawal, Imran Aziz, Christopher J. Black, Maura Corsetti, Farag Shuweihdi, Maria Eugenicos, Peter A. Paine, Alexander C. Ford, Peter J. Whorwell, Shrikant I. Bangdiwala, Olafur S. Palsson, Ami D. Sperber, Dipesh H. Vasant

Summary: This study compared the prevalence of disorders of gut brain interaction (DGBI) in the UK with other countries and found that the proportion of DGBI participants was lower in the UK. The prevalence of 14 out of 22 Rome IV DGBI was similar between the UK and other countries, while some specific DGBI were more prevalent in the UK. Differences in opioid prescribing, cultural, dietary, and lifestyle factors may contribute to variations in the prevalence of DGBI between the UK and other countries.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

No Data Available